SHENZHEN FANGHEAN TECHNOLOGY CO., LTD. – Trademark Portfolio
Entity Type: 99
SHENZHEN FANGHEAN TECHNOLOGY CO., LTD. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 28 (Toys & Sporting Goods) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include KING RELAX. The owner is based in SHENZHEN.
ROOM 1509, BUILDING 9, PHASE II, TIANAN YUNGU INDUSTRIAL PARK, GANGTOU COMMUNITY, BANTIAN STREET, LONGGANG DISTRICT,
SHENZHEN 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
SHENZHEN FANGHEAN TECHNOLOGY CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does SHENZHEN FANGHEAN TECHNOLOGY CO., LTD. have?
SHENZHEN FANGHEAN TECHNOLOGY CO., LTD. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does SHENZHEN FANGHEAN TECHNOLOGY CO., LTD. file in?
SHENZHEN FANGHEAN TECHNOLOGY CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 28 (Toys & Sporting Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are SHENZHEN FANGHEAN TECHNOLOGY CO., LTD.'s most well-known trademarks?
SHENZHEN FANGHEAN TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as KING RELAX. These are among 2 currently registered trademarks in the portfolio.
What is SHENZHEN FANGHEAN TECHNOLOGY CO., LTD.'s trademark registration success rate?
SHENZHEN FANGHEAN TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.